The following quote is an example of truly stunning ignorance of costs in the biopharma sphere.
Next time you go to the AGM instead of sniffing around try asking Itescu why the share price has gone backwards for 10 years or what they have to show for the $500m they have raised in that same time.
DYOR on costs to get one treatment from an idea to the end of a Phase 3 trial. While your at it try that for Big Pharma and a cellular medicine candidate.
The following quote is an example of truly stunning ignorance of...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.025(2.29%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.13 | $1.05 | $8.152M | 7.517M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 69963 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 73154 | 3 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.07 |
Change
-0.025 ( 2.84 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.13 | $1.05 | 1873215 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| MSB (ASX) Chart |